Clinical trial Recruiting at 1 site Observational

FST Decision Support to Help Timely Therapy for Kids with AKI Risk

Official title: Furosemide Stress Test Implementation and Outcomes in Critically Ill Children at High Risk for Acute Kidney Injury: A Hybrid Study

Run by Children's Hospital Medical Center, Cincinnati · NCT07718464 · Data updated 2026-11-12

This study tests whether adding a clinical decision support tool to the electronic medical record helps clinicians use the furosemide stress test in critically ill children at high risk for severe AKI.

Quick facts

Study typeObservational
SexAll
Enrollment120 (estimated)
SponsorChildren's Hospital Medical Center, Cincinnati
Academic / other
Locations1 site (Cincinnati, Ohio)
StatusRecruiting
StartedMay 27, 2026
Main results expectedMay 2028
Study endsJune 2028
Registry record updatedJuly 22, 2026
Trial IDNCT07718464 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children admitted to the PICU who have RAI ≥ 8 and NGAL ≥ 150 ng/mL.

Probably not a fit

Patients not meeting the high-risk RAI/NGAL criteria or those already on renal replacement therapy before admission may derive less benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will use risk markers like the Renal Angina Index and NGAL to identify high-risk PICU patients and then compare outcomes before and after introducing a decision-support tool to standardize the furosemide stress test. The project uses a hybrid effectiveness-implementation approach to see if clinicians find the tool acceptable and feasible and whether it reduces fluid overload and helps predict dialysis needs. The effort builds on prior work with AKI risk stratification and biomarkers to guide management in critically ill children. The goal is to determine if a standardized FST pathway improves timely decision-making around dialysis and overall outcomes.

Why it matters

Potential benefit: If successful, the tool could standardize FST use, potentially reducing fluid overload and aiding earlier, more appropriate dialysis decisions.

How similar studies have gone: FST and AKI biomarker approaches have shown promise in adults; pediatric-specific implementation studies are less established, making this largely exploratory in pediatrics.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Admitted to the pediatric intensive care unit (PICU)
* Renal Angina Index (RAI) greater than or equal to 8 (RAI+)
* Urine NGAL greater than or equal to 150 ng/mL (NGAL+)

Exclusion Criteria:

* Receipt of renal replacement therapy prior to PICU admission

Where it's running

  • Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio, United States
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.